Zuari Agro Chemicals Ltd (ZUARI)
🎯 Key Takeaways
- Zuari Agro Chemicals is navigating a sharp earnings correction following a period of volatility, transitioning from a high-margin, cash-generative phase to a more constrained operational environment. The company's financial trajectory shows significant revenue and profit volatility, with recent quarters reflecting margin pressure and one-time gains influencing profitability.
- Revenue grew 228.4% QoQ to ₹615 in Q1FY27.
- ⚠️ High earnings volatility due to exposure to commodity prices, foreign exchange movements, and agricultural seasonality.
- Market Cap
- ₹933
- P/E Ratio
- 1.0
- P/B Ratio
- 0.45
- ROE
- 45.0%
- ROCE
- 46.3%
- Debt/Equity
- 0.31
- Promoter
- 65.2%
📖 The Story
Zuari Agro Chemicals is navigating a sharp earnings correction following a period of volatility, transitioning from a high-margin, cash-generative phase to a more constrained operational environment. The company's financial trajectory shows significant revenue and profit volatility, with recent quarters reflecting margin pressure and one-time gains influencing profitability. Management is focused on structural simplification and liquidity management, but the business remains exposed to commodity and foreign exchange risks.
📰 What's Happening
The board approved Q1 FY26 standalone and consolidated financial results on July 31, 2026, which included a 6-month extension on ICD repayment, providing near-term cash flow relief. The company also disclosed gains from the derecognition of its stake in MCFL and asset sales, which contributed to reported profits. Additionally, on June 19, 2026, shareholders approved the appointment of Nitin M. Kantak as Managing Director and Pramod Kumar Gupta as a Non-Executive Director following an e-voting process conducted between June 24 and July 23, 2026. The annual report for FY2025-26 was made accessible online, and the 17th AGM is scheduled for September 16, 2026, via video conference.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,423 | 344 | 187 | 615 |
| Operating Profit | 149 | 5 | -19 | 54 |
| OPM % | 10.4% | 1.5% | -10.3% | 8.8% |
| Net Profit | 840 | 40 | -25 | 119 |
| EPS | ₹191.68 | ₹9.43 | ₹-5.94 | ₹28.17 |
The company's financial performance has been highly volatile, with revenue declining sharply from ₹1,423 crore in September 2025 to ₹187 crore in December 2025, followed by a partial recovery to ₹615 crore in June 2026. Operating profitability swung from a strong ₹149 crore operating profit and 10.4% margin in September 2025 to a loss of ₹19 crore in December 2025, with a modest rebound to ₹54 crore in June 2026. Net profit mirrored this trend, turning negative in Q3 FY26 before recovering to ₹119 crore in Q1 FY26, driven partly by non-operational gains. This volatility reflects both market headwinds and the impact of one-time financial events on reported earnings.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance in the reviewed filings beyond confirming the AGM date and reporting schedule. The focus appears to be on operational stabilization, capital structure management, and regulatory compliance, with no disclosed strategic expansion or margin improvement roadmap. The extension of ICD repayment suggests near-term liquidity management is a priority, but there is no public commentary on demand trends, pricing power, or investment plans in the available disclosures.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 |
| Reserves | 1,814 | 1,734 | 2,047 | 2,488 |
| Borrowings | 634 | 1,565 | 642 | 607 |
| Total Liabilities | 5,026 | 4,795 | 3,251 | 4,076 |
| Fixed Assets | 865 | 1,815 | 137 | 137 |
| Investments | 1,428 | 1,336 | 2,581 | 2,879 |
| Total Assets | 5,026 | 4,795 | 3,251 | 4,076 |
The balance sheet shows a decline in total assets from ₹5,026 crore in March 2025 to ₹4,076 crore in March 2026, primarily due to the derecognition of MCFL and asset sales, which reduced investments and associated liabilities. Borrowings decreased slightly from ₹634 crore to ₹607 crore, while equity and reserves remained relatively stable. The extension of ICD repayment by six months improves near-term liquidity, but the company continues to carry a moderate debt burden relative to equity, with a D/E of 0.34 as of March 2026.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +511 |
| Investing | -122 |
| Financing | -494 |
| Net Cash Flow | -104 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 65.2% | 65.2% | 65.2% | 65.2% |
| FII | 2.9% | 2.7% | 2.8% | 2.3% |
| DII | 0.1% | 0.1% | 0.1% | 0.1% |
| Public | 26.7% | 27.0% | 26.8% | 26.9% |
| # Shareholders | 47,405 | 45,524 | 44,493 | 43,594 |
Promoter holding remains stable at 65.21% across all reporting periods, indicating no dilution or stake sale. Foreign institutional investor (FII) holding has fluctuated slightly, peaking at 2.85% in Q2 FY26 and declining to 2.34% in Q1 FY27, while Domestic Institutional Investor (DII) holding remains minimal and stable around 0.09%. The number of public shareholders has gradually increased, suggesting growing retail participation. There are no signs of significant institutional exit, but foreign interest appears to be waning marginally.
⚖️ Peer Comparison — Fertilizers
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| COROMANDEL | 52,811 | 28.8 | 21.0% | — | 0.07 |
| FACT | 49,511 | 1779.4 | 9.2% | — | 1.29 |
| CHAMBLFERT | 16,575 | 8.6 | 22.6% | — | 0.10 |
| PARADEEP | 15,998 | 14.9 | 14.5% | — | 1.01 |
| GSFC | 6,043 | 8.7 | 7.4% | — | 0.00 |
| RCF | 5,978 | 13.4 | 10.2% | — | 0.80 |
| NFL | 3,184 | 8.7 | 15.8% | — | 0.73 |
| SPIC | 1,296 | 6.3 | 14.9% | — | 0.51 |
| MADRASFERT | 943 | 13.3 | 9.5% | — | -49.36 |
| ZUARI | 933 | 1.0 | 50.7% | — | 0.34 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. High earnings volatility due to exposure to commodity prices, foreign exchange movements, and agricultural seasonality. 2. Margin pressure evident in recent quarters, with operating margins turning negative in key periods. 3. Dependence on a few large customers or distributors, though not explicitly disclosed, is a structural risk in the fertilizer distribution space. 4. Execution risk around integration following MCFL derecognition and asset sales, which may affect cash flow predictability and operational focus.
📋 Recent Filings
- 🔴 Announcement2026-09-30Zuari Agro Chemicals announced full repayment of Rs. 44 crore in inter-corporate deposits from Zuari Industries, clearing all outstanding balances. Th…
- Announcement2026-09-28Zuari Agro Chemicals announced that its trading window will close on 1 October 2026 and remain shut until 48 hours after the unaudited Q3 results are …
- 🔴 Announcement2026-09-18Zuari Agro Chemicals repaid Rs. 214.50 Crore of inter-corporate deposits (ICDs) to Zuari Industries, reducing its total ICD exposure from Rs. 258.50 C…
- 🟡 voting results2026-09-17At the 17th Annual General Meeting on 16 September 2026, shareholders approved all five resolutions including the adoption of audited financial statem…
- 🟡 Board Meeting2026-09-16Zuari Agro Chemicals held its 17th AGM on 16 September 2026 via video conference, adopting audited financials for FY2025-26, reappointing Saroj Kumar …
- 🔴 annual report2026-08-26Zuari Agro Chemicals announced that its 2025-26 Annual Report is accessible via the company website at www.zuari.in/investor/annual_reports, specifica…
- Announcement2026-08-13Zuari Agro Chemicals announced that the Regional Director of the Ministry of Corporate Affairs has finalized compounding orders resolving past complia…
- 🟡 Board Meeting2026-07-31Zuari Agro Chemicals approved standalone and consolidated Q1 FY26 results, extended ICD repayment by 6 months, appointed SNSK & Associates as internal…
- Announcement2026-07-30Zuari Agro Chemicals received two interim orders from the Western Region Director of the Ministry of Corporate Affairs regarding compounding applicati…
- Financial Results2026-07-20Zuari Agro Chemicals announced a board meeting on July 31, 2026, to approve unaudited standalone and consolidated financial results for the quarter en…
🧠 Analyst's Read
Zuari Agro Chemicals is undergoing a transitional phase marked by financial volatility and structural changes, with limited visibility into sustainable earnings growth. Investors should monitor the sustainability of profitability post-one-time gains, commodity input cost trends, and management's ability to stabilize operations. The lack of forward guidance and persistent margin weakness warrant close scrutiny of future earnings quality and cash flow generation.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ZUARI files new disclosures
Track ZUARI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ZUARI — FreeFree account · 2 AI queries/day